Просмотр кода страницы EPR1

{{Short description|Withdrawn database record}}
'''Effector cell peptidase receptor 1''', also known as '''EPR1''', is a withdrawn database record.<ref name="entrez">{{cite web | title = Entrez Gene: EPR1 effector cell peptidase receptor 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8475}}{{dead link|date=July 2025|bot=medic}}{{cbignore|bot=medic}}</ref>

This locus represents an antisense transcript of the [[survivin]] locus. This record was withdrawn in collaboration with HGNC. It was defined by L26245.1, which appears to be a cloning artifact ({{cite journal | pmid = 10891443 | volume=96 | title=The elusive factor Xa receptor: failure to detect transcripts that correspond to the published sequence of EPR-1 | date=July 2000 | journal=Blood | pages=145–8 | vauthors=Zaman GJ, Conway EM | issue=1 | doi=10.1182/blood.v96.1.145}}).(This information come from https://www.ncbi.nlm.nih.gov/gene?term=L26245.1)<ref name="entrez" />

==References==
{{reflist}}

==Further reading==
{{refbegin | 2}}
*{{cite journal  | author=Altieri DC |title=Xa receptor EPR-1 |journal=FASEB J. |volume=9 |issue= 10 |pages= 860–5 |year= 1995 |pmid= 7615156 |doi=  10.1096/fasebj.9.10.7615156|doi-access=free |s2cid=8767504 }}
*{{cite journal  | author=Altieri DC |title=Splicing of effector cell protease receptor-1 mRNA is modulated by an unusual retained intron |journal=Biochemistry |volume=33 |issue= 46 |pages= 13848–55 |year= 1994 |pmid= 7947793 |doi=10.1021/bi00250a039  }}
*{{cite journal  | author=Altieri DC |title=Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa |journal=J. Biol. Chem. |volume=269 |issue= 5 |pages= 3139–42 |year= 1994 |doi=10.1016/S0021-9258(17)41838-2 |pmid= 8106347 |doi-access=free }}
*{{cite journal  | vauthors=Ambrosini G, Plescia J, Chu KC |title=Activation-dependent exposure of the inter-EGF sequence Leu83-Leu88 in factor Xa mediates ligand binding to effector cell protease receptor-1 |journal=J. Biol. Chem. |volume=272 |issue= 13 |pages= 8340–5 |year= 1997 |pmid= 9079657 |doi=10.1074/jbc.272.13.8340  |display-authors=etal|doi-access=free }}
*{{cite journal  | vauthors=Ambrosini G, Adida C, Sirugo G, Altieri DC |title=Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting |journal=J. Biol. Chem. |volume=273 |issue= 18 |pages= 11177–82 |year= 1998 |pmid= 9556606 |doi=10.1074/jbc.273.18.11177  |doi-access=free }}
*{{cite journal  | vauthors=Zaman GJ, Conway EM |title=The elusive factor Xa receptor: failure to detect transcripts that correspond to the published sequence of EPR-1 |journal=Blood |volume=96 |issue= 1 |pages= 145–8 |year= 2000 |pmid= 10891443 |doi=  10.1182/blood.v96.1.145}}
*{{cite journal  | vauthors=Bouchard BA, Silveira JR, Tracy PB |title=On the role of EPR-1 or an EPR-1-like molecule in regulating factor Xa incorporation into platelet prothrombinase |journal=Thromb. Haemost. |volume=86 |issue= 4 |pages= 1133–5 |year= 2002 |pmid= 11686347 |doi=  10.1055/s-0037-1616557|s2cid=7764246 }}
*{{cite journal  | vauthors=Yamamoto T, Manome Y, Nakamura M, Tanigawa N |title=Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer |journal=Eur. J. Cancer |volume=38 |issue= 17 |pages= 2316–24 |year= 2003 |pmid= 12441269 |doi=10.1016/S0959-8049(02)00247-2  }}
*{{cite journal  | vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899  | pmc=139241 |bibcode=2002PNAS...9916899M |display-authors=etal|doi-access=free }}
*{{cite journal  | vauthors=Yao XQ, Liu FK, Li JS |title=Significance of effector protease receptor-1 expression and its relationship with proliferation and apoptotic index in patients with primary advanced gastric adenocarcinoma |journal=World J. Gastroenterol. |volume=10 |issue= 9 |pages= 1262–7 |year= 2004 |pmid= 15112339 |doi=  10.3748/wjg.v10.i9.1262|pmc=4622763 |display-authors=etal |doi-access=free }}
*{{cite journal  | vauthors=Oh JH, Yang JO, Hahn Y |title=Transcriptome analysis of human gastric cancer |journal=Mamm. Genome |volume=16 |issue= 12 |pages= 942–54 |year= 2006 |pmid= 16341674 |doi= 10.1007/s00335-005-0075-2 |s2cid=69278 |display-authors=etal}}
{{refend}}

[[Category:Genetics]]